Stress
and Memory Decline Linked
< Jun.
13, 2007 > -- If you want your mind to
stay healthy into your golden years, don't
worry, be happy, according to a recent article
published in Neurology.
That could be the message of new
research that shows those prone to worry, anxiety,
or depression are more likely to develop mild cognitive
impairment (MCI), a condition often considered a
precursor to the more debilitating Alzheimer's disease.
"MCI is now recognized as a very
early sign of incipient Alzheimer's disease," says
Dr. Robert S. Wilson, lead author of the study
and a neuropsychologist at the Rush Alzheimer's Disease
Center in Chicago. "We found that among healthy elderly
people without evidence of cognitive dysfunction
at the beginning of the study, chronic distress predicted
the development of MCI."
"This is consistent with 20 years
of literature on the subject," adds Dr. Sam Gandy,
chairman of the Alzheimer's
Association's medical and scientific advisory
council and director of the Farber Institute for
Neurosciences at Thomas Jefferson University in Philadelphia.
But moving from these findings
to knowledge that can really help individuals could
be problematic.
"Quantifying stress is like quantifying
mental activity," Dr. Gandy says. "These are things
that are very difficult to standardize and quantify
and measure from one human to the next. It's a big
challenge to get to something specific."
"The most important implications
are down the road," Dr. Wilson adds.
For now, even stressed people
should not get more stressed by the research, another
expert advises.
"Fifty percent of individuals
who have mild cognitive impairment do not go on to
develop dementia," says Dr. Gary J. Kennedy, director
of geriatric psychiatry at Montefiore Medical Center
in New York City. "It's not what's called a stable,
highly reliable diagnosis. People should not be alarmed
by the study."
Dr. Wilson and his colleagues
had hypothesized that distress might play a role
in the beginnings of Alzheimer's.
The authors used data from two
larger studies - the Religious Orders Study and the
Memory and Aging Project - to explore the relationship
between psychological distress and mild cognitive
impairment.
At
the beginning of the study, 1,256 participants
with no signs of cognitive impairment
completed a test designed to assess how prone they
were to distress and negative emotions. They were
asked their degree of agreement with such statements
as "I am not a worrier," "I often feel tense and
jittery," and "I often get angry at the way people
treat me."
Participants were further evaluated
every year for 12 years.
During that time, 482 people -
38 percent - developed mild cognitive impairment.
Those who most often experienced
negative emotions were more than 40 percent more
likely to develop mild cognitive impairment than
those who were least prone to these emotions. This
suggests that chronic psychological distress is a
risk factor for mild cognitive impairment, the researchers
say.
And
the findings were independent of depression. "We do think depression is somehow
associated with an increased risk of dementia, but
this [study] controlled for depression," Dr. Kennedy
says.
It
is unclear why this might
be the case.
"If this is a vulnerability factor
for developing Alzheimer's, the big question is how
is it working, what's the neurobiology connecting
this," Dr. Wilson says. "If we could understand the
mechanism, it could open up new avenues for preventing
or at least delaying the onset of symptoms."
Always consult your physician
for more information.
|
Find
a Physician at
St. John's Mercy
or call our Physician Referral Service at 314-FOR-DOCS
According
to the Alzheimer's
Association, Alzheimer’s (AHLZ-high-merz) disease
is a progressive brain disorder
that gradually destroys a person's memory and ability to learn,
reason, make judgments, communicate,
and carry out daily activities.
As
Alzheimer’s progresses, individuals
may also experience changes in personality
and behavior, such as anxiety, suspiciousness or agitation, as
well as delusions or hallucinations.
Alzheimer's disease is distinguished from other
forms of dementia by characteristic changes in the brain that are
visible only upon microscopic examination during autopsy.
Brains affected by Alzheimer's disease often
show presence of the following:
- fiber tangles within nerve cells
(neurofibrillary tangles)
- clusters of degenerating nerve
endings (neuritic plaques)
Another characteristic of Alzheimer's disease
is the reduced production of certain brain chemicals necessary
for communication between nerve cells, especially acetylcholine,
as well as norepinephrine, serotonin, and somatostatin.
There is not a single, comprehensive test for
diagnosing Alzheimer's disease. By ruling out other conditions
through a process of elimination, physicians or other specialists
can obtain a diagnosis of probable Alzheimer's disease with approximately
90 percent accuracy.
At this time, there is no cure for Alzheimer's,
no way of slowing down the progression of this disease, and no
treatment available to reverse the deterioration of Alzheimer's
disease.
New research findings give reason for hope,
and several drugs are being studied in clinical trials to determine
if they can slow the progress of the disease or improve memory
for a period of time.
There are some medications available to assist
in managing some of the most troubling symptoms of Alzheimer's
disease, including the following:
- depression
- behavioral disturbance
- sleeplessness
In managing the disease, physical exercise and
social activity are important, as are proper nutrition, health
maintenance, and a calm and well-structured environment.
Always consult your physician for more information.
|